Cargando…
Limitations of caspofungin in the treatment of obstructive pyonephrosis due to Candida glabrata infection
BACKGROUND: Caspofungin is a new antifungal agent with high-level activity against a number of Candida species including those that are resistant to azoles. Its good safety profile and low nephrotoxicity makes it an attractive drug to treat fungal infections in patients with compromised renal functi...
Autores principales: | Schelenz, Silke, Ross, Calum N |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1560384/ https://www.ncbi.nlm.nih.gov/pubmed/16895593 http://dx.doi.org/10.1186/1471-2334-6-126 |
Ejemplares similares
-
Micafungin versus caspofungin in the treatment of Candida glabrata infection: a case report
por: Yamada, Shoko Merrit, et al.
Publicado: (2016) -
Cellular apoptosis: An alternative mechanism of action for caspofungin against Candida glabrata
por: Aryamloo, Parisa, et al.
Publicado: (2019) -
Identification of Genes in Candida glabrata Conferring Altered Responses to Caspofungin, a Cell Wall Synthesis Inhibitor
por: Rosenwald, Anne G., et al.
Publicado: (2016) -
Essential Role for the Phosphatidylinositol 3,5-Bisphosphate Synthesis Complex in Caspofungin Tolerance and Virulence in Candida glabrata
por: Choudhary, Deepak Kumar, et al.
Publicado: (2019) -
Pyonephrosis and pyocystis
por: Rojas-Moreno, Christian
Publicado: (2016)